U.S. Markets closed

Jounce Therapeutics, Inc. (JNCE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.13-0.48 (-6.31%)
At close: 04:00PM EST
7.13 0.00 (0.00%)
After hours: 06:03PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.61
Bid5.01 x 1400
Ask7.24 x 800
Day's Range7.11 - 7.64
52 Week Range5.03 - 14.84
Avg. Volume506,533
Market Cap365.116M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)-1.15
Earnings DateMay 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.40
  • Benzinga

    Notable Jounce Therapeutics Insider Makes $15M Sale

    Mark Levin, Insider at Jounce Therapeutics (NASDAQ:JNCE), made a large insider sell on November 12, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Levin sold 1,900,000 shares of Jounce Therapeutics at a price of $8.38. The total transaction amounted to $15,922,000. Following the transaction, Levin still owns 1,432,638 shares of the company, worth $12,678,846. Jounce Therapeutics shares are trading down 1.67% at

  • GlobeNewswire

    Jounce Therapeutics to Present at Upcoming Investor Conferences in November

    CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that company management will participate at the following upcoming investor conferences in November: 5th Annual Cowen IO Next Summit: Fireside chat on Monday, November 15, 2021 at 10:45 a.m. ET.33rd Annual Piper Sandler Healthcare Conference: Fireside chat availabl

  • Motley Fool

    Jounce Therapeutics, inc (JNCE) Q3 2021 Earnings Call Transcript

    JNCE earnings call for the period ending September 30, 2021.